Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunitybio Inc
(NQ:
IBRX
)
4.709
+0.219 (+4.88%)
Streaming Delayed Price
Updated: 11:24 AM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,316,087
Open
4.500
Bid (Size)
4.700 (7)
Ask (Size)
4.710 (25)
Prev. Close
4.490
Today's Range
4.450 - 4.730
52wk Range
3.100 - 10.53
Shares Outstanding
391,156,513
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ImmunityBio Reports Third-Quarter 2024 Financial Results
November 12, 2024
From
ImmunityBio, Inc.
Via
Business Wire
IMMUNITYBIO ALERT: Bragar Eagel & Squire, P.C. is Investigating ImmunityBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 30, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Performance
YTD
-10.14%
-10.14%
1 Month
+32.65%
+32.65%
3 Month
+17.72%
+17.72%
6 Month
-33.11%
-33.11%
1 Year
+16.27%
+16.27%
More News
Read More
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
October 28, 2024
Via
Benzinga
Top 2 Health Care Stocks That May Fall Off A Cliff This Month
October 25, 2024
Via
Benzinga
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
October 28, 2024
Via
Benzinga
Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?
October 27, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Jeff Bezos Ends Washington Post's 36-Year Tradition Of Endorsements, Leaving Staff 'Roiled'
October 25, 2024
Via
Benzinga
Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday
October 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 25, 2024
Via
Benzinga
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
October 25, 2024
Via
Benzinga
First Patients Dosed in Phase 1 Clinical Study of ImmunityBio’s CAR-NK Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma
October 24, 2024
From
ImmunityBio, Inc.
Via
Business Wire
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
October 23, 2024
Via
Benzinga
Texas Instruments Posts Strong Q3 Results, Joins Valmont Industries, Lithia Motors, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
October 23, 2024
Via
Benzinga
ImmunityBio to Participate in the Jefferies London Healthcare Conference
October 21, 2024
From
ImmunityBio, Inc.
Via
Business Wire
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
September 12, 2024
Via
Benzinga
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
September 09, 2024
Via
Benzinga
ImmunityBio Presents Positive Long-Term Overall Survival Data in Non-Small Cell Lung Cancer Patients and Announces Registrational Intent Phase 3 Trials with ANKTIVA® and Checkpoint Immunotherapy at World Conference on Lung Cancer
September 09, 2024
From
ImmunityBio, Inc.
Via
Business Wire
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
Top 3 Health Care Stocks That Are Set To Fly This Quarter
August 16, 2024
Via
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Via
Benzinga
IBRX Stock Earnings: ImmunityBio Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
Via
InvestorPlace
ImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval
August 12, 2024
From
ImmunityBio, Inc.
Via
Business Wire
ImmunityBio Announces Study of ANKTIVA® in Combination with the AdHER2DC Cancer Vaccine as a Potential Therapy to Control Endometrial Cancer
August 06, 2024
From
ImmunityBio, Inc.
Via
Business Wire
IMMUNITYBIO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX
July 26, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.